Table 3.
Association analysis of OSCC presence, using the peptides intensities normalized by global standards, measured by SRM.
| Peptidesa | Peptide Sequence | Odds ratiob |
IC 95% | p-value |
|---|---|---|---|---|
| ANXA1_1 | TPAQFDADELR | 0.231 | 0.38–1.413 | 0.113 |
| ANXA1_2 | NALLSLAK | 0.231 | 0.38–1.413 | 0.113 |
| ANXA1_3 | ALYEAGER | 1 | 0.198–5.045 | 1 |
| CFB_1 | YGLVTYATYPK | 12.250 | 1.268–118.361 | 0.030* |
| CFB_2 | VSEADSSNADWVTK | 4.333 | 0.708–26.531 | 0.113 |
| CFB_3 | DISEVVTPR | 4.333 | 0.708–26.531 | 0.113 |
| C1R_1 | DYFIATCK | 4.333 | 0.708–26.531 | 0.113 |
| C1R_2 | NLPNGDFR | 0.231 | 0.038–1.413 | 0.113 |
| C3_1 | LMNIFLK | 4.333 | 0.708–26.531 | 0.113 |
| C3_2 | SSLSVPYVIVPLK | 4.333 | 0.708–26.531 | 0.113 |
| C3_3 | TFISPIK | 12.250 | 1.268–118.361 | 0.030* |
| C4B_1 | TTNIQGINLLFSSR | 12.250 | 1.268–118.361 | 0.030* |
| C4B_2 | VGDTLNLNLR | 1.846E9 | 0.0-iv | 0.998 |
| C4B_3 | GSFEFPVGDAVSK | 12.250 | 1.268–118.361 | 0.030* |
| LCN2_1 | MYATIYELK | 2 | 0.381–10.511 | 0.413 |
| LCN2_2 | TFVPGCQPGEFTLGNIK | 1 | 0.198–5.045 | 1 |
| LCN2_3 | SYPGLTSYLVR | 1 | 0.198–5.045 | 1 |
| LRG1_1 | DLLLPQPDLR | 12.250 | 1.268–118.361 | 0.030 * |
| LRG1_2 | YLFLNGNK | 12.250 | 1.268–118.361 | 0.030* |
| LRG1_3 | VAAGAFQGLR | 1.846E9 | 0.0-iv | 0.998 |
| FAM49B_1 | MSLFYAEATPMLK | 2 | 0.381–10.511 | 0.413 |
| FAM49B_2 | VMLETPEYR | 1 | 0.198–5.045 | 1 |
| SERPINA1_1 | LSITGTYDLK | 1.612E9 | 0.0-iv | 0.998 |
| SERPINA1_2 | SVLGQLGITK | 8.4 | 0.879–80.265 | 0.065 |
| SERPINA1_3 | AVLTIDEK | 12.250 | 1.268–118.361 | 0.030 * |
| SERPINE1_1 | FIINDWVK | 0.5 | 0.095–2.628 | 0.413 |
| SERPINE1_2 | GMISNLLGK | 0.867 | 0.164–4.579 | 0.866 |
| SLPI | CLDPVDTPNPTR | 0.952 | 0.179–5.081 | 0.954 |
| TAGLN2_1 | IQASTMAFK | 1.0 | 0.198–5.045 | 1.000 |
| TAGLN2_2 | TLMNLGGLAVAR | 1.0 | 0.198–5.045 | 1.000 |
| TAGLN2_3 | NVIGLQMGTNR | 1.0 | 0.198–5.045 | 1.000 |
Categorized as ‘low’ and ‘high’.
Odds ratio for Low/High.
Indeterminate value.
p<0.05